Yes Sam, 30x return will be absolute minimum if P2B is a hit with DMD trial in Europe....closer to x100.
Question is: how aggressively will they pursue CD49d horizontal strategy?
DMD, Asthma, MS.... can’t do it all.
Hope we get a little more insights to their strategy once IP protection is in place.
.
Chart, page-1697
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $10.13K | 98.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 432950 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 292603 | 3 |
View Market Depth
| Last trade - 10.22am 10/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |